Bioequivalence evaluation of norfloxacin tablets based on in vitro - in vivo correlation
Pakistan Journal of Pharmaceutical Sciences. 2011; 24 (4): 421-426
in English
| IMEMR
| ID: emr-137539
ABSTRACT
Present study was designed to establish in-vitro and in-vivo correlation [IVIVC] of two immediate release tablet formulations of 400mg Norfloxacin [Drug A as test and Drug B as reference]. Dissolution study was conducted in 0.1 N HC1 using USP apparatus II. In-vivo evaluation was carried out in 18 healthy humans according to a single dose, two-sequence, and cross-over randomized with a wash-out period of one week. After dosing, serial blood samples were collected for a period of 10 hours. Plasma harvested from blood, was analyzed for norfloxacin by a sensitive, reproducible and accurate HPLC method. Various pharmacokinetic parameters were determined from plasma concentrations for both the formulations. Non-significant difference was found for test/reference ratio of these parameters and the value of F was found to be 0.99 which is in good agreement with the limits given in PDA and WHO guidelines for such parameters. Difference factor [f[1]], similarity factor [f[2]] and level A IVIVC were evaluated showing that drug A is bioequivalent to drug B
Search on Google
Index:
IMEMR (Eastern Mediterranean)
Main subject:
Tablets
/
Biological Availability
/
Therapeutic Equivalency
/
Norfloxacin
/
Chromatography, High Pressure Liquid
/
Cross-Over Studies
/
Area Under Curve
Type of study:
Controlled clinical trial
Limits:
Female
/
Humans
/
Male
Language:
English
Journal:
Pak. J. Pharm. Sci.
Year:
2011
Similar
MEDLINE
...
LILACS
LIS